Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane preconditioning in brain dead organ donors
NCT02341833Phase 4Unknown
- Sponsor
- University of Liège
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sevoflurane in ischemia-reperfusion injury (IRI), sponsored by University of Liège. Primary endpoint: Composite outcome of liver function at 1 week. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02341833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341833.